News

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling…

With members of the EMJ team jetting off across Europe this month to attend a grand total of four medical congresses, which will of course be reviewed…

With September having drawn to a close, the European Medical Journal (EMJ) looks back at the awareness campaigns we have supported this month: World…

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….

BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the…

PROTECTION against alcoholic liver disease may become possible thanks to new research surrounding the protein fibroblast growth factor 21 (FGF21). A…

PIONEERING research from the University of Maryland, Baltimore, Maryland, USA, has found a potential link between a relatively under-studied gene and…

A MUTATION altering the effect that levofloxacin, a quinolone antibiotic, has on pathogens causing urinary tract infections (UTI) has been identified by…